(Q44951134)

English

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

based on heuristic

inferred from title

Pellegrino Musto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Monia Lunghi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Antonella Poloni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pasquale Niscola

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Carlo Finelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Renato Zambello

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Massimo Breccia

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giuliana Alimena

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

28 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

90

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

345-348

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23336938%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Azacytidine causes complex DNA methylation responses in myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patients

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12079

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44951134&oldid=1245675772"